[HTML][HTML] Vitamin D and cancer: an historical overview of the epidemiology and mechanisms
This is a narrative review of the evidence supporting vitamin D's anticancer actions. The first
section reviews the findings from ecological studies of cancer with respect to indices of solar …
section reviews the findings from ecological studies of cancer with respect to indices of solar …
[HTML][HTML] Targeting the tumor microenvironment in acute myeloid leukemia: The future of immunotherapy and natural products
C Hino, B Pham, D Park, C Yang, MHK Nguyen, S Kaur… - Biomedicines, 2022 - mdpi.com
The tumor microenvironment (TME) plays an essential role in the development, proliferation,
and survival of leukemic blasts in acute myeloid leukemia (AML). Within the bone marrow …
and survival of leukemic blasts in acute myeloid leukemia (AML). Within the bone marrow …
Vitamin C and D supplementation in acute myeloid leukemia
PL Mouchel, E Bérard, S Tavitian, N Gadaud… - Blood …, 2023 - ashpublications.org
Recent studies have highlighted the role of vitamin C and D in acute myeloid leukemia
(AML). In 2018, we changed our practices to add both vitamins to the supportive care for all …
(AML). In 2018, we changed our practices to add both vitamins to the supportive care for all …
[HTML][HTML] Vitamin D derivatives in acute myeloid leukemia: The matter of selecting the right targets
E Marcinkowska - Nutrients, 2022 - mdpi.com
Acute myeloid leukemia (AML) is an aggressive and often fatal hematopoietic malignancy. A
very attractive way to treat myeloid leukemia, called “differentiation therapy”, was proposed …
very attractive way to treat myeloid leukemia, called “differentiation therapy”, was proposed …
Loss of the vitamin D receptor triggers senescence in chronic myeloid leukemia via DDIT4-mediated DNA damage
Y Xu, W Qi, C Zheng, Y Li, Z Lu, J Guan… - Journal of Molecular …, 2024 - academic.oup.com
Chronic myeloid leukemia (CML) is a hematopoietic malignancy driven by the fusion gene
BCR:: ABL1. Drug resistance to tyrosine kinase inhibitors (TKIs), due to BCR:: ABL1 …
BCR:: ABL1. Drug resistance to tyrosine kinase inhibitors (TKIs), due to BCR:: ABL1 …
[PDF][PDF] Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients 2022, 14, 1448
A Muñoz, WB Grant - 2022 - pdfs.semanticscholar.org
This is a narrative review of the evidence supporting vitamin D's anticancer actions. The first
section reviews the findings from ecological studies of cancer with respect to indices of solar …
section reviews the findings from ecological studies of cancer with respect to indices of solar …
Overexpressed fibroblast growth factor receptors increase 1, 25-dihydroxyvitamin D-dependent differentiation of acute myeloid leukemia cells
A Marchwicka, U Nowak, A Grembowska… - The Journal of Steroid …, 2022 - Elsevier
Many malignancies are driven by mutations within the gene for fibroblast growth factor
receptor 1 (FGFR1). Previously, we have shown that signal transduction from the FOP2 …
receptor 1 (FGFR1). Previously, we have shown that signal transduction from the FOP2 …
Vitamin D and Cancer: An historical overview of the epidemiology and mechanisms
A Muñoz Terol, WB Grant - 2022 - digital.csic.es
This is a narrative review of the evidence supporting vitamin D's anticancer actions. The first
section reviews the findings from ecological studies of cancer with respect to indices of solar …
section reviews the findings from ecological studies of cancer with respect to indices of solar …
Les mutations d'IDH2 dans la leucémie aigue myéloïde confèrent une sensibilité spécifique à l'inhibition du métabolisme des acides aminés branchés (BCAA)
M Heiblig - 2022 - theses.hal.science
La leucémie aiguë myéloïde (LAM) est une maladie complexe et hétérogène sur le plan
moléculaire qui se caractérise par l'accumulation de progéniteurs myéloïdes immatures. Les …
moléculaire qui se caractérise par l'accumulation de progéniteurs myéloïdes immatures. Les …